Switch to:
More From Other Websites
Data on Proprietary BTK Inhibitor, ARQ 531, Demonstrating Inhibition of Wild Type and C481S Mutant... Dec 04 2016
Preclinical Data on Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness in the Treatment... Dec 03 2016
ARQULE INC Financials Nov 16 2016
Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A? Nov 10 2016
ArQule, Inc. :ARQL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 Nov 08 2016
Edited Transcript of ARQL earnings conference call or presentation 7-Nov-16 2:00pm GMT Nov 07 2016
ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 07 2016
Q3 2016 ArQule Inc Earnings Release - Before Market Open Nov 07 2016
ArQule reports 3Q loss Nov 07 2016
ArQule reports 3Q loss Nov 07 2016
ArQule Reports Third Quarter 2016 Financial Results Nov 07 2016
Advancements in ArQule’s Proprietary Pipeline to be Highlighted at the 2016 American Society of... Nov 03 2016
ARQULE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Oct 26 2016
ArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September... Oct 24 2016
ArQule To Report Third Quarter 2016 Financial Results On November 7, 2016 Oct 24 2016
Can The Uptrend Continue for ArQule (ARQL)? Sep 28 2016
ArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September... Sep 21 2016
ETF’s with exposure to ArQule, Inc. : September 19, 2016 Sep 19 2016
ArQule Announces Publication of Manuscript Highlighting Preclinical Activity of FGFR Inhibitor, ARQ... Sep 15 2016
ETF’s with exposure to ArQule, Inc. : September 8, 2016 Sep 08 2016
ETF’s with exposure to ArQule, Inc. : August 25, 2016 Aug 25 2016
ETF’s with exposure to ArQule, Inc. : August 11, 2016 Aug 11 2016
ArQule, Inc. :ARQL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 Aug 05 2016
Edited Transcript of ARQL earnings conference call or presentation 3-Aug-16 1:00pm GMT Aug 03 2016
ArQule To Report Second Quarter 2016 Financial Results On August 3, 2016 Aug 03 2016
ArQule reports 2Q loss Aug 03 2016
ArQule reports 1Q loss May 04 2016
ArQule To Report First Quarter 2016 Financial Results On May 4, 2016 May 03 2016
ArQule to Present at the 15th Annual Needham Healthcare Conference on April 12, 2016 Apr 18 2016
ArQule reports 4Q loss Feb 29 2016
ArQule Announces Orphan Drug Designation in Cholangiocarcinoma and Clinical Update for ARQ 087 Dec 15 2015
ArQule and Daiichi Sankyo Announce Completion of Accrual in METIV-HCC Phase 3 Trial of Tivantinib... Dec 10 2015
ArQule reports 3Q loss Nov 04 2015
ArQule reports 2Q loss Aug 05 2015
ArQule reports 1Q loss May 06 2015
ArQule reports 4Q loss Mar 04 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK